Chemours Posts $1.81/Shr Loss in 2Q, Deepening Financial Strain
CC sits 52% above its 52-week low of $10.44.
Summary
Chemours reported a 2Q loss of $1.81 per share, a sharp negative result that underscores ongoing financial distress. The company had already disclosed a $386M net loss for fiscal 2025 and warned it lacked sufficient funds to meet obligations, so this quarterly loss extends that trajectory. The recent PFAS settlement with the EPA and West Virginia DEP adds a layer of legal cost pressure, though the direct impact on this quarter's numbers isn't specified. With a market cap around $2.7B and shares at $15.84, the magnitude of the loss is material and likely to erode confidence further. No guidance or call details were provided, but the result alone signals deepening cash burn and potential covenant or liquidity concerns.
At the time of this announcement, CC was trading at $15.84 on NYSE in the Manufacturing sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $10.44 to $28.67. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.